The present invention relates to novel pyrimidones of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly novel pyrimidones of the general formula (I).
1
本发明涉及一种新的
嘧啶酮,其通式为(I),它们的衍
生物、类似物、互变异构体、立体异构体、多晶形态、
水合物、溶剂合物、药用盐及含有它们的药用成分。本发明更具体地涉及通式(I)的新
嘧啶酮。